A detailed history of True Wealth Design, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, True Wealth Design, LLC holds 107 shares of NEO stock, worth $792. This represents 0.0% of its overall portfolio holdings.

Number of Shares
107
Holding current value
$792
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$9.09 - $18.61 $972 - $1,991
107 New
107 $1.02 Million
Q4 2022

Feb 15, 2023

BUY
$6.45 - $12.07 $5,160 - $9,656
800 New
800 $7.39 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $932M
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.